- Health
- SEE MORE
- classical
- general
- talk
- News
- Family
- Bürgerfunk
- pop
- Islam
- soul
- jazz
- Comedy
- humor
- wissenschaft
- opera
- baroque
- gesellschaft
- theater
- Local
- alternative
- electro
- rock
- rap
- lifestyle
- Music
- como
- RNE
- ballads
- greek
- Buddhism
- deportes
- christian
- Technology
- piano
- djs
- Dance
- dutch
- flamenco
- social
- hope
- christian rock
- academia
- afrique
- Business
- musique
- ελληνική-μουσική
- religion
- World radio
- Zarzuela
- travel
- World
- NFL
- media
- Art
- public
- Sports
- Gospel
- st.
- baptist
- Leisure
- Kids & Family
- musical
- club
- Culture
- Health & Fitness
- True Crime
- Fiction
- children
- Society & Culture
- TV & Film
- gold
- kunst
- música
- gay
- Natural
- a
- francais
- bach
- economics
- kultur
- evangelical
- tech
- Opinion
- Government
- gaming
- College
- technik
- History
- Jesus
- radio
- movies
- services
- Church
- podcast
- Education
- international
- Transportation
- Other
- kids
- podcasts
- philadelphia
- Noticias
- love
- sport
- Salud
- film
- and
- 4chan
- Disco
- Stories
- fashion
- Arts
- interviews
- hardstyle
- entertainment
- humour
- medieval
- literature
- alma
- Cultura
- video
- TV
- Science
- en
Developing Momelotinib to Treat the Cancer Myelofibrosis with Dr. Barbara Klencke Sierra Oncology
Dr. Barbara Klencke, Chief Development Officer, Sierra Oncology talks about the development of momelotinib for myelofibrosis, a rare blood cancer.\xa0 Momelotinib's unique mechanism of action allows it to address all three key symptoms of myelofibrosis, including the debilitating anemia which can be exacerbated by currently available therapies.\xa0 The Phase 3 MOMENTUM Clinical Trial evaluating momelotinib for patients with MF is currently recruiting globally.\xa0 To learn more: momentumtrial.com
#myelofibrosis #JAKInhibitor #ClinicalTrial #RareCancer